Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership8,808 shares
Latest Disclosed Value $ 1,227,571
Point72 Asset Management, L.P. ownership in GILD / Gilead Sciences, Inc.

On May 15, 2026 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 8,808 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,227,571 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Gilead Sciences, Inc..

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 48,700 of underlying shares valued at $6,787,319 USD and put options representing 12,400 of underlying shares valued at $1,728,188 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 8,808 8,808 1,228 0.0016
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 0 -164,728 -100.00 0 -100.00
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 164,728 -346,008 -67.75 18,263 -68.09 0.0359
2025-07-21 2025-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 510,736 -345,921 -40.38 57,228 -27.68 0.1306
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 510,736 -345,921 57,228 0.1306
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 856,657 -1,448,613 -62.84 79,129 -59.06 0.1743
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 2,305,270 1,793,145 350.14 193,274 450.07 0.4913
2024-09-16 2024-06-30 13F/A-2 GILEAD SCIENCES COM 375558103 512,125 154,525 43.21 35,137 34.14 0.0919
2024-08-19 2024-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 512,125 154,525 35,137 0.0919
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 512,125 154,525 35,137 0.0919
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 357,600 357,600 26,194 0.0635
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 0 -602 -100.00 0 -100.00
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 602 602 45 0.0001
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 0 -46,585 -100.00 0 -100.00
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 46,585 46,585 3,865 0.0120
2023-05-15 2022-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 0 -562,900 -100.00 0 -100.00
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 0 -562,900 0
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 562,900 562,900 34,725 0.1387
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 0 -125,000 -100.00 0 -100.00
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 125,000 125,000 7,431 0.0295
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 0 -1,813,444 -100.00 0 -100.00
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 1,813,444 1,201,301 196.25 117,203 228.64 0.5475
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 612,143 612,143 35,663 0.1740
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 0 -402,631 -100.00 0 -100.00
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 402,631 402,631 26,163 0.1376
2019-11-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 0 -10,100 -100.00 0 -100.00
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 10,100 10,100 682 0.0036
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 0 -548,917 -100.00 0 -100.00
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 548,917 -698,365 -55.99 34,335 -64.35 0.1677
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 1,247,282 -1,923,449 -60.66 96,303 -57.13 0.3971
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 3,170,731 92,165 2.99 224,615 -3.22 0.8964
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 3,078,566 2,836,662 1,172.64 232,093 1,239.26 0.9702
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 241,904 241,904 17,330 0.0748
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM 375558103 0 -1,272,910 -100.00 0 -100.00
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 1,272,910 706,810 124.86 90,097 134.32 0.5055
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM 375558103 566,100 566,100 38,450 0.2143
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 0 -141,000 -100.00 0 -100.00
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 141,000 -518,100 -78.61 11,156 -79.71 0.0784
2016-08-15 2016-06-30 13F GILEAD SCIENCES COM 375558103 659,100 658,400 94,057.14 54,982 85,809.38 0.3741
2016-05-16 2016-03-31 13F GILEAD SCIENCES COM 375558103 700 700 0.00 64 0.0005
2015-08-14 2015-06-30 13F GILEAD SCIENCES COM 375558103 0 -1,158,000 -100.00 0 -100.00
2015-05-15 2015-03-31 13F GILEAD SCIENCES COM 375558103 1,158,000 96,900 9.13 113,635 13.61 0.7745
2015-02-17 2014-12-31 13F GILEAD SCIENCES COM 375558103 1,061,100 1,061,100 100,019 0.7018
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM Call 48,700 13.79 6,787 29.20 n/a n/a n/a
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM Call 42,800 5,253 n/a n/a n/a
2025-07-21 2025-03-31 13F/A GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM Call 0 0 n/a n/a n/a
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM Call 150,000 13,856 n/a n/a n/a
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM Call 25,000 1,930 n/a n/a n/a
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM Call 1,000,000 71,640 n/a n/a n/a
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM Call 28,700 0.00 2,031 4.21 n/a n/a n/a
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM Call 28,700 1,949 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM Put 12,400 -26.19 1,728 -16.20 n/a n/a n/a
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM Put 16,800 2,062 n/a n/a n/a
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-07-21 2025-03-31 13F/A GILEAD SCIENCES COM Put 75,000 8,404 n/a n/a n/a
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM Put 75,000 8,404 n/a n/a n/a
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM Put 500,000 36,305 n/a n/a n/a
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM Put 500,000 35,390 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.